Correlation between single nucleotide polymorphism of prothrombin gene G20210 and deep vein thrombosis after total joint replacement

National Medical Journal of China

Volumn 89, Issue 11, 2009, Pages 782-785

  Jiang, Jun ^a   Guan, Zhen Peng ^a   Lü, Hou Shan ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Arthroplasty, replacement; Prothrombin; Veinous thrombosis

Indexed keywords

DNA; PROTHROMBIN;

ARTICLE; CHINESE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; DNA SEQUENCE; GENE FREQUENCY; GENE MUTATION; HUMAN; JOINT PROSTHESIS; MAJOR CLINICAL STUDY; MORBIDITY; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ARTHROPLASTY, REPLACEMENT; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTOPERATIVE COMPLICATIONS; PROTHROMBIN; RISK FACTORS; VENOUS THROMBOSIS;

EID: 77954936490     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2009.11.015     Document Type: Article

References (26)

1. Poort SR, Rosendaal FR, Reistsma PH, et al. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and increase in venous thrombosis. Blood, 1996,88:3698-3703.
2. Westrich GH, Weksler BB, Glueck CJ, et al. Correlation of thrombophilia and hypofibrinolysis with pulmonary embolism following total hip arthroplasty: an analysis of genetic factors. J Bone Joint Surg Am, 2002,84:2161-2167.
3. Wahlander K, Larson G, Lindahl TL, et al. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or knee replacement surgery. Thromb Haemost, 2002,87:580-585.
4. Lu Y, Zhao Y, Liu G, et al. Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population. Thromb Res, 2002,106:7-12.
5. Bai C, Pan J, Li X. Factor V Leiden and PTG20210A gene mutation in patients with venous thrombosis and healthy blood donors. Zhonghua Yi Xue Za Zhi, 1999,79:900-902.
6. Ripoll LD, Thomas PS, drouet O. Multiplex PCR-mediated site-directed mutagenesis for one-step determination of FV Leiden and G20210A transition of the prothrombin gene. Thromb Haemost, 1997,78:960-961.
7. Folsom AR, Cushman M, Tsai MY. Prospective study of the G202010A polymorphism in the prothrombin gene, plasma prothrombin concentration, and incidence of venous thromboembolism. Am J Hamatol, 2002,71:285-290.
8. Zalavras CG, Giotopoulou S, Dokou E, tl al. Prevalence of the G20210A prothrombin gene mutation in Northwestern Greece and association with venous thromboembolism. Int Angiol, 2003,22:55-57.
9. Granel B, Morange PE, Serratrice J, et al. Heterozygous prothrombin gene mutation G20210A and associated. Rev Med Interne, 2002,24:282-287.
10. Westrich GH, Weksler BB, Glueck CJ, et al. Correlation of thrombophilia and hypofibrinolysis with pulmonary embolism following total hip arthroplasty: an analysis of genetic factors. J Bone Joint Surg Am, 2002,84:2161-2167.
11. Wahlander K, Larson G, Lindahl TL, et al. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or knee replacement surgery. Thromb Haemost, 2002,87:580-585.
12. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med, 2001,344:1222-1231.
13. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest, 2004,126 Suppl:338-400.
14. Anderson FA Jr, Wheeler HB. Venous thromboembolism: risk factors and prophylaxis. Clin Chest Med, 1995,16:235-251.
15. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest, 2001,119:132-175.
16. White KH, Henderson MC. Risk factors for venous thromboembolism after total hip and knee replacement surgery. Curr Opin Pulm Med, 2002,8:365-371.
17. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet, 1999,353:1167-1173.